Classic Benjamin Graham Stock Screener
Free Value Investing for Intelligent Investors across Global Equity Markets, as recommended by Warren Buffett.
| Company Name | MIC | HQ | Fiscal Year | Last Updated | Curr Code | Previous Close | Graham Number | Graham Number(%) | NCAV/ NetNet | NCAV/ NetNet(%) | Graham Grade | Intrinsic Value | Intrinsic Value(%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 131 | Alaska Air Group Inc (ALK) | XNYS | US | 2024-12-31 | 6 days ago | USD | 45.18 | 37.78 | 83.63% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 132 | Accenture PLC (ACN) | XNYS | IE | 2024-08-31 | 6 days ago | USD | 282.35 | 105.66 | 37.42% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 133 | ACNB Corp (ACNB) | XNAS | US | 2024-12-31 | 6 days ago | USD | 40.63 | 55.51 | 136.63% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 134 | Acorda Therapeutics Inc (ACOR) | XNAS | US | 2022-12-31 | 1 year ago | USD | 1.35 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 135 | Ares Commercial Real Estate Corp (ACRE) | XNYS | US | 2024-12-31 | 6 days ago | USD | 3.60 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 136 | Aclaris Therapeutics Inc (ACRS) | XNAS | US | 2024-12-31 | 6 days ago | USD | 1.14 | 0.00 | 0.00% | 0.57 | 49.76% | Ungraded | 0.00 | 0.00% |
| 137 | AcelRx Pharmaceuticals Inc (ACRX) | XNAS | US | 2022-12-31 | 1 year ago | USD | 0.99 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |
| 138 | Acacia Research Corp (ACTG) | XNAS | US | 2024-12-31 | 6 days ago | USD | 2.89 | 0.00 | 0.00% | 1.86 | 64.33% | Ungraded | 0.00 | 0.00% |
| 139 | Aldeyra Therapeutics Inc (ALDX) | XNAS | US | 2024-12-31 | 6 days ago | USD | 2.19 | 0.00 | 0.00% | 1.18 | 53.94% | Ungraded | 0.00 | 0.00% |
| 140 | Adaptimmune Therapeutics PLC (ADAP) | XNAS | GB | 2024-12-31 | 6 days ago | USD | 0.24 | 0.00 | 0.00% | 0.00 | 0.00% | Ungraded | 0.00 | 0.00% |